Fenlean (FLZ) is a tyrosine kinase Src inhibitor, a synthetic cyclic derivative of squamous amide from Annona glabra, with cytoprotective activity, which protects tyrosine hydroxylase function in a chronic MPTP/prostaglandin-type mouse model of Parkinsons disease.Fenlean inhibits the production of Abeta in the mitochondria, which may be useful in the study of age-related macular degeneration and Parkinsons disease. and Parkinsons.
Molekulargewicht:
449.5
Reinheit:
98.99%
CAS Nummer:
[863193-70-8]
Formel:
C26H27NO6
Target-Kategorie:
Beta Amyloid|||Src
T31773
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten